Annual Securities Report — FY2025
What Perseus Proteomics Inc. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-22View the original on EDINET
How much it says
53Typical
What moved here
26named for the first time
Its own wording
54terms
Which filing this is
17/ 17newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
The Company reported on the development status of its existing pipeline—PPMX-T002, PPMX-T003 and PPMX-T004—as well as its business and financial condition, including trends in antibody research support and antibody and reagent sales. Research and development expenses were ¥573,593 thousand and revenue was ¥135,507 thousand. The filing also updated disclosures on the progress of ANKL clinical trials, continued development following the return of the PPMX-T002/T004 rights, various contracts and governance.
Komori's summary of this document, not the document's own words.53Typical
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
61
Detailed
33
Thin
62
Detailed
75
Very detailed
15
Almost nothing
68
Detailed
27
Almost nothing
31
Thin
60
Detailed
79
Very detailed
50
Typical
R&D spend6億円Money spent making new things.
Cash left over6億円Cash from the business, less what went into equipment.
Spent on equipment9百万円Plants, machines — things meant to last.
Employees35Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.